La série Réalités Industrielles publie trimestriellement des dossiers thématiques sur des sujets importants pour le développement industriel et économique. Piloté par un spécialiste du secteur sous l’égide du Comité de rédaction de la série, chaque dossier présente une large gamme de points de vue complémentaires, en faisant appel à des auteurs issus à la fois de l’enseignement et de la recherche, de l’entreprise, de l’administration ainsi que du monde politique et associatif. Voir la gouvernance de la série

 

 
 

   linkedin

Numéros précédents

Rechercher :

 

Réalités Industrielles

2022
2021
Années depuis 1985
 

Gérer & Comprendre

2022
2021
Toutes les années
 
Gérer & Comprendre -
English language online selection
 
Responsabilité & Environnement
2022
2021
Toutes les années
 
Enjeux numériques
2022
2021
Toutes les années
 
Financial Regulation
and Governance
Banks
Insurance
Markets
Payments and monetay instruments
International financial
regulation
Fintechs
 

La Gazette de la société

et des techniques

2022
2021

Toutes les années 

 
Numéros anciens des Annales des Mines
1794-1914
1915-1943
Lois et réglementation
1919 – 1942
Articles

1946 – 1991

 
Le Club des Annales des Mines

Toutes les années

 

Histoire des Ingénieurs
des Mines

Documents de synthèse
Directeurs, professeurs,
anciens élèves des Ecoles des mines
Les principaux textes législatifs ou règlementaires
Biographies relatives à des ingénieurs des mines décédés
Composition du corps des ingénieurs
Autres documents sur les mines, carrières, géologie.
 
La Lettre des Annales des Mines
2022
Toutes les années
   

 

 

         
 

 

Réalités Industrielles - Novembre 2021 - La  compétitivité de la France au sein de l’Europe

 

 

 

Télécharger gratuitement
la revue complète

 

 

 

Novembre 2021 - La compétitivité de la France au sein de l’Europe

Responsible innovation in neurotechnology, practical examples from translational projects

By Tracy LAABS
PhD, Chief Development Officer, Wyss Center for Bio and Neuroengineering

 

Progress in neurotechnology is advancing rapidly driven by unmet needs for therapies to treat neurological disorders. New technologies raise ethical questions and responsible innovation is needed at every step of the development process.
Here we describe two research projects breaking new ground in neurotechnology and neurobiology respectively. The first, a brain-computer interface, enables people who are completely locked-in to communicate in real time using their brain signals to control a communication device. The second assesses the feasibility of using photobiomodulation (PBM) as a therapy in the fight against neurodegenerative disorders like Parkinson’s and Alzheimer’s disease.
We briefly consider the ethical aspects of both projects and conclude that organizations developing new neurotechnologies should consult with experts in neuroethics and put quality systems which require development in line with accepted international standards in place early in the development process. They should additionally engage in an open dialogue with society around the impact of their technology. Finally, they should anticipate potential unintended use of new technologies and engage with professional organizations to facilitate the translation of applied research ethics into government policy.

Télécharger gratuitement l'article

Retour au sommaire


November 2021 - French competitiveness within Europe

Responsible innovation in neurotechnology, practical examples from translational projects

 

Tracy Laabs,
PhD, Chief Development Officer, Wyss Center for Bio and Neuroengineering
Progress in neurotechnology is advancing rapidly driven by unmet needs for therapies to treat neurological disorders.

 

New technologies raise ethical questions and responsible innovation is needed at every step of the development process.
Here we describe two research projects breaking new ground in neurotechnology and neurobiology respectively. The first, a brain-computer interface, enables people who are completely locked-in to communicate in real time using their brain signals to control a communication device. The second assesses the feasibility of using photobiomodulation (PBM) as a therapy in the fight against neurodegenerative disorders like Parkinson’s and Alzheimer’s disease.
We briefly consider the ethical aspects of both projects and conclude that organizations developing new neurotechnologies should consult with experts in neuroethics and put quality systems which require development in line with accepted international standards in place early in the development process. They should additionally engage in an open dialogue with society around the impact of their technology. Finally, they should anticipate potential unintended use of new technologies and engage with professional organizations to facilitate the translation of applied research ethics into government policy.

 

Retour au sommaire

 


 

 

Les Annales des Mines

Télédoc 797, 120, rue de Bercy – 75572 – Paris cedex 12
Courriel :
redactiondesannalesdesmines.cgeiet@finances.gouv.fr